FDA official logo
GSRS logoPFDA official logo

REMOGLIFLOZIN ETABONATE

UNII:TR0QT6QSUL
Formula:C26H38N2O9
Preferred Substance Name:REMOGLIFLOZIN ETABONATE
InChIKey:UAOCLDQAQNNEAX-ABMICEGHSA-N

  • 442201-24-3
  • .BETA.-D-GLUCOPYRANOSIDE, 5-METHYL-4-((4-(1-METHYLETHOXY)PHENYL)METHYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-3-YL, 6-(ETHYL CARBONATE)
  • 5-METHYL-1-(PROPAN-2-YL)-4-((4-((PROPAN-2-YL)OXY)PHENYL)METHYL)-1H-PYRAZOL-3-YL 6-O-(ETHOXYCARBONYL)-.BETA.-D-GLUCOPYRANOSIDE
  • 5-METHYL-4-(4-(1-METHYLETHOXY)BENZYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-3-YL 6-O- (ETHOXYCARBONYL)-.BETA.-D-GLUCOPYRANOSIDE
  • BHV-091009
  • ETHYL (((2R,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-((4-(4-ISOPROPOXYBENZYL)-1-ISOPROPYL-5-METHYL-1H-PYRAZOL-3-YL)OXY)TETRAHYDRO-2H-PYRAN-2-YL)METHYL) CARBONATE
  • GSK189075
  • GSK-189075
  • GSK189075A
  • GSK-189075A
  • REMOGLIFLOZIN ETABONATE [INN]
  • REMOGLIFLOZIN ETABONATE [USAN]
  • REMOGLIFLOZIN ETABONATE [WHO-DD]



UNII - TR0QT6QSUL | UNII Search Service